Free Trial

Blueprint Medicines (BPMC) Insider Trading & Ownership

→ top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad)
Free BPMC Stock Alerts
$92.26
-0.03 (-0.03%)
(As of 04/24/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Blueprint Medicines (NASDAQ:BPMC) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
3.88%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
10
Amount Of
Insider Selling
(Last 12 Months)
$13.71 M
Get BPMC Insider Trade Alerts

Want to know when executives and insiders are buying or selling Blueprint Medicines stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

BPMC Insider Buying and Selling by Quarter

Ad Traders Agency
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.
Click here now for the full details of this stock that’s set to rocket in the AI revolution…

Blueprint Medicines Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/28/2024Michael LandsittelCFOSell5,000$95.00$475,000.00  
3/20/2024Jeffrey W AlbersDirectorSell25,073$87.28$2,188,371.44  
3/15/2024Michael LandsittelCFOSell13,734$87.78$1,205,570.52  
3/7/2024Christina RossiCOOSell6,070$90.69$550,488.30  
3/7/2024Jeffrey W AlbersDirectorSell11,033$90.69$1,000,582.77  
3/7/2024Kate HavilandCEOSell12,464$90.69$1,130,360.16  
3/7/2024L. Becker HewesInsiderSell3,097$90.69$280,866.93  
3/7/2024Michael LandsittelCFOSell5,003$90.69$453,722.07  
3/7/2024Tracey L MccainEVPSell5,194$90.69$471,043.86  
3/4/2024Christopher K MurrayInsiderSell621$93.65$58,156.65  
2/28/2024Christopher K MurrayInsiderSell5,000$100.00$500,000.00  
1/25/2024Jeffrey W AlbersDirectorSell25,000$81.91$2,047,750.00  
12/22/2023Ariel HurleyInsiderSell714$90.00$64,260.00  
12/7/2023Christopher K MurrayInsiderSell5,000$75.00$375,000.00  
12/4/2023Christopher K MurrayInsiderSell600$71.43$42,858.00  
11/30/2023Jeffrey W AlbersDirectorSell5,000$70.55$352,750.00  
11/24/2023Jeffrey W AlbersDirectorSell15,000$67.51$1,012,650.00  
11/3/2023Jeffrey W AlbersDirectorSell1,485$60.13$89,293.05  
11/1/2023Jeffrey W AlbersDirectorSell3,881$60.02$232,937.62  
10/26/2023Christopher K MurrayInsiderSell600$56.40$33,840.00  
10/4/2023Fouad NamouniInsiderSell3,769$48.06$181,138.14  
9/28/2023Jeffrey W AlbersDirectorSell6,898$50.17$346,072.66  
8/25/2023Jeffrey W AlbersDirectorSell10,000$50.16$501,600.00  
6/5/2023Percy H CarterInsiderSell2,307$52.06$120,102.42  
(Data available from 1/1/2013 forward)

BPMC Insider Trading Activity - Frequently Asked Questions

Who is on Blueprint Medicines's Insider Roster?

The list of insiders at Blueprint Medicines includes Ariel Hurley, Christina Rossi, Christopher K Murray, Debra Durso-Bumpus, Fouad Namouni, George Demetri, Jeffrey W Albers, Kate Haviland, L. Becker Hewes, Mark Alan Goldberg, Michael Landsittel, Percy H Carter, and Tracey L Mccain. Learn more on insiders at BPMC.

What percentage of Blueprint Medicines stock is owned by insiders?

3.88% of Blueprint Medicines stock is owned by insiders. Learn more on BPMC's insider holdings.

Which Blueprint Medicines insiders have been buying company stock?

The following insider purchased BPMC shares in the last 24 months: Kate Haviland ($48,378.00).

How much insider buying is happening at Blueprint Medicines?

Insiders have purchased a total of 1,100 BPMC shares in the last 24 months for a total of $48,378.00 bought.

Which Blueprint Medicines insiders have been selling company stock?

The following insiders have sold BPMC shares in the last 24 months: Ariel Hurley ($64,260.00), Christina Rossi ($714,305.75), Christopher K Murray ($1,246,604.65), Debra Durso-Bumpus ($375,550.00), Fouad Namouni ($415,140.24), Jeffrey W Albers ($11,994,527.05), Kate Haviland ($1,433,741.76), L. Becker Hewes ($280,866.93), Michael Landsittel ($2,271,652.35), Percy H Carter ($234,124.50), and Tracey L Mccain ($622,792.82).

How much insider selling is happening at Blueprint Medicines?

Insiders have sold a total of 273,657 Blueprint Medicines shares in the last 24 months for a total of $19,653,566.05 sold.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:BPMC) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners
The #1 Biotech Stock to Have on Your Radar in 2024…
Huge Alerts
He Is Giving Away Bitcoin
Crypto Swap Profits
Bitcoin Rockets To Record High But Buy THIS Instead
Paradigm Press
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
Traders Agency
Exposed: 10 CENT Crypto to Explode April 20th?
True Market Insiders
Fed launches fourth dollar overhaul
Stansberry Research
The #1 Crypto for 2024
InvestorPlace
Don’t Miss Out on the AI Gold Rush That’s Just Getting Started
Banyan Hill Publishing